Circadian Rhythm Sleep Disorder, Free Running Type (ICD-10-CM G47.24)
For G47.24, this page provides an evidence-aligned clinical overview of Circadian rhythm sleep disorder, free running type in the ICD-10-CM nervous-system chapter.
Overview
For G47.24, the practical challenge is not finding words; it is choosing wording that supports better care decisions, and tied to practical follow-up steps for G47.24.
High-quality entries avoid generic statements and instead tie each clinical claim to observable findings or timeline data, with direct relevance to G47.24 safety planning.
Sleep-related presentations often require combining symptom narrative with behavior, timing, and daytime function patterns, and this improves continuity across teams handling G47.24.
The goal is practical clarity: safer handoffs, cleaner documentation, and fewer missed deterioration signals, so the note remains actionable for G47.24.
Symptoms
For G47.24, symptom review should capture onset speed, progression pattern, and impact on routine activities, which often changes next-visit planning for G47.24.
Include caregiver observations when episodes are intermittent or awareness is reduced during events, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G47.24.
Pair subjective symptoms with objective findings whenever possible to reduce drift between visits, a detail that improves chart clarity for G47.24.
Ask what changed first, what changed most recently, and what the patient considers the main current limitation, especially useful when counseling patients about G47.24.
Causes
A chronology from trigger to peak to recovery can reveal causal structure that static descriptions miss, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G47.24.
Medication interaction, withdrawal, or dosing inconsistency should be tested against the event timeline, which often changes next-visit planning for G47.24.
Likely causes for G47.24 should be ranked by plausibility and consequence, not listed as an unprioritized checklist, and helpful for safer handoff notes linked to G47.24.
In recurrent presentations, compare the current pattern to historical baseline rather than treating each event as isolated, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G47.24.
Diagnosis
Chart quality improves when ordered and non-ordered investigations are both explained, a detail that improves chart clarity for G47.24.
Imaging, electrophysiology, sleep testing, or labs should be justified by differential priorities, not habit, something that usually alters follow-up cadence in G47.24.
Begin with focused history and neurologic exam, then expand testing when results will change action, especially useful when counseling patients about G47.24.
Diagnostic strategy for G47.24 should answer clear clinical questions tied to immediate management decisions, and helpful for safer handoff notes linked to G47.24.
Differential Diagnosis
State why key alternatives were deprioritized; this improves both safety and audit defensibility, a detail that improves chart clarity for G47.24.
High-risk mimics deserve early mention even when they are not the leading hypothesis, something that usually alters follow-up cadence in G47.24.
Differential diagnosis for G47.24 should balance probability with harm if a diagnosis is missed, and helpful for safer handoff notes linked to G47.24.
Ranking should be revised as data arrives to avoid anchoring on the first impression, which often changes next-visit planning for G47.24.
Prevention
Medication reconciliation at every transition can prevent avoidable neurologic deterioration, which often changes next-visit planning for G47.24.
Early response to small warning changes can prevent high-cost emergency escalations, which often changes next-visit planning for G47.24.
Written action plans outperform verbal-only guidance when symptoms recur between visits, a detail that improves chart clarity for G47.24.
For this profile, prevention priority is follow-up reliability and care-transition safety, something that usually alters follow-up cadence in G47.24.
Prognosis
Realistic prognosis framing reduces anxiety and improves adherence to monitoring plans, which often changes next-visit planning for G47.24.
If trajectory plateaus or worsens, revisit working assumptions early, which often changes next-visit planning for G47.24.
Prognosis in G47.24 depends on etiology, baseline reserve, treatment timing, and follow-up continuity, and helpful for safer handoff notes linked to G47.24.
Objective milestones should guide reassessment frequency and treatment adjustments, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G47.24.
Red Flags
Emergency criteria should be written in plain language, not only coded terminology, a detail that improves chart clarity for G47.24.
Outpatient worsening with repeated falls, confusion, or severe headache needs expedited evaluation, a practical triage signal within episodic and paroxysmal disorders (g40-g47) for G47.24.
Escalate urgently for altered consciousness, new focal deficits, persistent vomiting, or rapidly progressive weakness, especially useful when counseling patients about G47.24.
Return instructions should specify symptoms, urgency level, and where to seek care, a detail that improves chart clarity for G47.24.
Risk Factors
If recent hospitalization or medication change occurred, reassess risk before keeping prior follow-up cadence, especially useful when counseling patients about G47.24.
A dynamic risk note is safer than a one-time risk snapshot copied across encounters, especially useful when counseling patients about G47.24.
Polypharmacy and adherence barriers can shift risk more than diagnosis label alone, a detail that improves chart clarity for G47.24.
Social determinants such as transport limits, fragmented care, or low support at home can increase adverse-event risk, a detail that improves chart clarity for G47.24.
Treatment
Medication choices should reflect symptom pattern, comorbidity profile, and tolerability history, something that usually alters follow-up cadence in G47.24.
Document what success looks like at 2 weeks, 6 weeks, and next follow-up interval, and helpful for safer handoff notes linked to G47.24.
A treatment plan is stronger when it states both what to do now and what to do if progress stalls, something that usually alters follow-up cadence in G47.24.
Non-pharmacologic supports (sleep, rehabilitation, behavioral strategies, caregiver coaching) often influence outcomes substantially, a detail that improves chart clarity for G47.24.
Medical References
Got questions? We’ve got answers.
Need more help? Reach out to us.
G47.24 corresponds to Circadian rhythm sleep disorder, free running type. Use it when provider documentation supports this diagnosis with code-level specificity. Clinical context: Circadian Rhythm Sleep Disorder, Free Running Type within Episodic and paroxysmal disorders (G40-G47), coding variant G 47 24.
Escalate testing when symptoms worsen, progression is atypical, or early results are non-diagnostic despite ongoing concern. Reassessment decisions should be documented for Circadian Rhythm Sleep Disorder, Free Running Type, with risk framing linked to Episodic and paroxysmal disorders (G40-G47) and coding variant G 47 24.
Prevention plans should combine trigger control, adherence support, and scheduled reassessment milestones. This care-planning guidance is tailored to Circadian Rhythm Sleep Disorder, Free Running Type and aligned with Episodic and paroxysmal disorders (G40-G47) risk-management goals for coding variant G 47 24.
Include onset pattern, progression, objective exam findings, differential rationale, and explicit follow-up thresholds. This guidance applies to Circadian Rhythm Sleep Disorder, Free Running Type and should be interpreted in the context of Episodic and paroxysmal disorders (G40-G47), coding variant G 47 24.
Maintain a symptom timeline to support faster, safer reassessment when deterioration occurs. This monitoring advice is tailored to Circadian Rhythm Sleep Disorder, Free Running Type and should be adapted to the patient's current neurologic baseline for coding variant G 47 24.

